Arlington, MA, United States of America

Arthur J Sytkowski



Average Co-Inventor Count = 1.7

ph-index = 12

Forward Citations = 484(Granted Patents)


Company Filing History:


Years Active: 1986-2003

Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Arthur J Sytkowski: Innovator in Pharmaceutical Sciences

Introduction

Arthur J Sytkowski is a prominent inventor based in Arlington, MA (US), known for his significant contributions to pharmaceutical sciences. With a total of 18 patents, he has made remarkable advancements in the field, particularly in the area of angiogenesis and erythropoietin.

Latest Patents

Sytkowski's latest patents include innovative pharmaceutical compositions that comprise troponin subunits, fragments, and analogs, aimed at inhibiting angiogenesis. These compositions are designed for the treatment of diseases or disorders involving angiogenesis, utilizing therapeutically effective amounts of troponin C, I, or T. Additionally, he has developed recombinant human erythropoietin with altered biological activity, which includes DNA encoding modified, secretable erythropoietin proteins. These proteins have a different ability to regulate the growth and differentiation of red blood cell progenitors compared to the wildtype recombinant erythropoietin.

Career Highlights

Throughout his career, Sytkowski has worked with esteemed organizations such as Beth Israel Deaconess Medical Center and Children's Medical Center Corporation. His work has significantly impacted the medical field, particularly in developing treatments that address critical health issues.

Collaborations

Sytkowski has collaborated with notable colleagues, including Jennifer Grodberg and Marsha A Moses, contributing to various research projects and advancements in pharmaceutical innovations.

Conclusion

Arthur J Sytkowski's contributions to pharmaceutical sciences through his numerous patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of effective treatments for complex medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…